Abstract
As pharmaceutical firms search for effective new ways to improve and reduce the time required to complete their paper-bound drug development process, a promising new technology known as imaging continues to be embraced with tremendous enthusiasm. Unfortunately, large investments are often made to address only small localized problems with no clear vision of how this investment can be leveraged and expanded in the future to gain a greater overall impact to the business as a whole. The process of creating such a vision and articulating it through a cohesive strategy can be a challenging effort even to the most progressive organization. To better prepare for short term decisions which will affect long term successes with imaging, this paper will address key issues and considerations when the strategic approach to imaging is taken.
Get full access to this article
View all access options for this article.
